Area of research
Genetics · Biotechnology · cancer
Research interest
Research interests include Glioma Diagnosis and Treatment, Cancer Research and Treatments, Immune cells in cancer, and Cancer, Hypoxia, and Metabolism.
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity
The multilayered transcriptional architecture of glioblastoma ecosystems
Deciphering the longitudinal trajectories of glioblastoma ecosystems by integrative single-cell genomics
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium
OS05.2.A DECIPHERING THE LONGITUDINAL TRAJECTORIES OF GLIOBLASTOMA ECOSYSTEMS BY INTEGRATIVE SINGLE-CELL GENOMICS
Mapping extrachromosomal DNA amplifications during cancer progression
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
Deep intravital brain tumor imaging enabled by tailored three-photon microscopy and analysis
Adenoviral delivery of the <i>CIITA</i> transgene induces T‐cell‐mediated killing in glioblastoma organoids
T-Cell-Mediated Killing in Glioblastoma Organoids induced by Adenoviral Delivery of the CIITA Transgene
Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts
Deep intravital brain tumor imaging enabled by tailored three-photon microscopy and analysis
Advancing preclinical cancer models to assess clinically relevant outcomes.
Glioblastoma hijacks neuronal mechanisms for brain invasion
Elucidating tumour‐associated microglia/macrophage diversity along glioblastoma progression and under <scp> <i>ACOD1</i> </scp> deficiency
Oncolytic H-1 parvovirus binds to sialic acid on laminins for cell attachment and entry
Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology
Primary and recurrent glioma patient-derived orthotopic xenografts (PDOX) represent relevant patient avatars for precision medicine
Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
Single‐cell transcriptomics reveals distinct inflammation‐induced microglia signatures
Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas
EGFL7 enhances surface expression of integrin α5β1 to promote angiogenesis in malignant brain tumors
Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas